DOI: 10.1055/s-00000069

Seminars in Liver Disease

References

Reau N, Robertson MN, Feng HP. , et al.
Concomitant proton pump inhibitor use does not reduce the efficacy of elbasvir/grazoprevir: a pooled analysis of 1,322 patients with hepatitis C infection.

Hepatol Commun 2017;
1 (08) 757-764

Download Bibliographical Data

Access:
Access:
Access: